We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Avg Time Held
21.7
quarters
Top 10 Avg Time Held
6.6
quarters
Top 20 Avg Time Held
9.9
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1626
Diversified Energy Company
DEC
$978M
| $58K | ﹤0.01% |
3,956
-4,048
| -51% | -$54.2K |
2025 Q1
1 quarter
|
|
1627
IDEX
IEX
$17.4B
| $57.8K | ﹤0.01% |
329
-4
| -1% | -$709 |
2013 Q2
48 quarters
|
|
1628
Dycom Industries
DY
$8.05B
| $57.7K | ﹤0.01% |
236
-256
| -52% | -$50.4K |
2024 Q3
3 quarters
|
|
1629
iShares Russell 3000 ETF
IWV
$20.6B
| $56.2K | ﹤0.01% |
160
-4,682
| -97% | -$1.52M |
2023 Q4
6 quarters
|
|
1630
Postal Realty Trust
PSTL
$692M
| $55.5K | ﹤0.01% |
3,770
+3,470
| +1,157% | +$47.6K |
2025 Q1
1 quarter
|
|
1631
UDR
UDR
$10.9B
| $53.6K | ﹤0.01% |
1,312
-11
| -0.8% | -$456 |
2024 Q3
3 quarters
|
|
1632
Block Inc
XYZ
$46.2B
| $53.3K | ﹤0.01% |
784
-398,528
| -100% | -$23.2M |
2020 Q2
20 quarters
|
|
1633
DELISTED
HilleVax
HLVX
| $52.7K | ﹤0.01% |
26,467
+2,038
| +8% | +$3.73K |
2022 Q4
10 quarters
|
|
1634
Akamai
AKAM
$14.6B
| $50.7K | ﹤0.01% |
636
-1,317
| -67% | -$102K |
2018 Q1
29 quarters
|
|
1635
Viatris
VTRS
$20.1B
| $49.7K | ﹤0.01% |
5,566
-4,209
| -43% | -$35.6K |
2013 Q2
48 quarters
|
|
1636
Clarus
CLAR
$135M
| $49.7K | ﹤0.01% |
14,317
-203
| -1% | -$688 |
2022 Q4
10 quarters
|
|
1637
Supernus Pharmaceuticals
SUPN
$2.49B
| $49.5K | ﹤0.01% |
1,572
-13
| -0.8% | -$417 |
2021 Q4
14 quarters
|
|
1638
El Pollo Loco
LOCO
$466M
| $49.3K | ﹤0.01% |
4,479
| – | – |
2024 Q3
3 quarters
|
|
1639
News Corp Class A
NWSA
$15.8B
| $48.8K | ﹤0.01% |
1,641
-20
| -1% | -$550 |
2024 Q1
5 quarters
|
|
1640
Enova International
ENVA
$4.4B
| $48.6K | ﹤0.01% |
436
+130
| +42% | +$12.4K |
2024 Q4
2 quarters
|
|
1641
American States Water
AWR
$3.28B
| $46.5K | ﹤0.01% |
607
+98
| +19% | +$7.69K |
2023 Q4
6 quarters
|
|
1642
Zentalis Pharmaceuticals
ZNTL
$239M
| $46.1K | ﹤0.01% |
39,736
-712,781
| -95% | -$940K |
2020 Q3
19 quarters
|
|
1643
Argan
AGX
$5.44B
| $46.1K | ﹤0.01% |
209
+10
| +5% | +$1.8K |
2024 Q3
3 quarters
|
|
1644
Solventum
SOLV
$14.5B
| $45.8K | ﹤0.01% |
604
-160
| -21% | -$11.3K |
2024 Q2
4 quarters
|
|
1645
WesBanco
WSBC
$3.54B
| $45.4K | ﹤0.01% |
1,435
+600
| +72% | +$18.1K |
2025 Q1
1 quarter
|
|
1646
Universal Health Services
UHS
$10.5B
| $45.1K | ﹤0.01% |
249
-9
| -3% | -$1.62K |
2024 Q1
5 quarters
|
|
1647
Boston Properties
BXP
$9.51B
| $44.9K | ﹤0.01% |
666
-22
| -3% | -$1.47K |
2013 Q2
48 quarters
|
|
1648
ABM Industries
ABM
$2.94B
| $43.4K | ﹤0.01% |
920
| – | – |
2024 Q1
5 quarters
|
|
1649
Mercury Systems
MRCY
$4.73B
| $43.1K | ﹤0.01% |
+801
| New | +$39K |
2025 Q2
0 quarters
|
|
1650
Origin Bancorp
OBK
$1.6B
| $41.8K | ﹤0.01% |
1,169
+17
| +1% | +$563 |
2025 Q1
1 quarter
|
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.